Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• Anyone who requires insulin therapy to manage their diabetes, whether type 1 or type 2, can benefit from automated insulin delivery

  80% confidence

• Bringing together the Instinct sensor with the well-established algorithm of the MiniMed 780G system makes for an extremely effective combination

  80% confidence

• Medtronic technologies and therapies treat 70 health conditions and transform the lives of two people every second, every hour, every day

  80% confidence

• MiniMed 780G system automatically adjusts insulin delivery every five minutes, responding to glucose changes, supporting more stable glucose control with fewer highs and lows and less daily decision-making

  80% confidence

• These milestones reflect unwavering commitment to expanding access and giving individuals living with diabetes more choice in how they manage their condition

  80% confidence

• Instinct sensor offers up to 15 days of wear and is the world's smallest and thinnest integrated CGM

  80% confidence

• More people living with type 2 diabetes will get access to life-changing technology improving their day-to-day experience in managing their diabetes

  80% confidence

• By broadening sensor and insulin options for the MiniMed 780G system, more people will benefit from automated insulin delivery that supports easier mealtimes, greater flexibility, and more confident diabetes management

  80% confidence

• Ultra rapid-acting insulin's faster onset may help reduce the impact of late or missed meal doses, allowing the insulin to catch up more effectively

  80% confidence